Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 18,605,000 | 19,380,000 | 18,653,000 | 16,208,000 | 18,044,000 |
| Cost of Goods | 5,737,000 | 5,989,000 | 5,406,000 | 4,691,000 | 5,515,000 |
| Gross Profit | 12,868,000 | 13,391,000 | 13,247,000 | 11,517,000 | 12,529,000 |
| Operating Expenses | 9,166,000 | 9,042,000 | 8,493,000 | 7,827,000 | 10,286,000 |
| Operating Income | 3,702,000 | 4,349,000 | 4,754,000 | 3,690,000 | 2,243,000 |
| Other Income | 602,000 | 69,000 | -74,000 | -942,000 | 20,000 |
| Pre-tax Income | 4,304,000 | 4,418,000 | 4,680,000 | 2,748,000 | 2,263,000 |
| Income Tax | 870,000 | 1,519,000 | 1,210,000 | 386,000 | 213,000 |
| Net Income Continuous | 2,842,000 | 2,378,000 | 3,097,000 | 2,059,000 | 1,871,000 |
| Net Income Discontinuous | 158,000 | 10,000 | 9,000 | 78,000 | 2,791,000 |
| Net Income | $3,000,000 | $2,388,000 | $3,106,000 | $2,137,000 | $4,662,000 |
| EPS Basic Total Ops | 1.53 | 1.23 | 1.60 | 1.11 | 2.40 |
| EPS Basic Continuous Ops | 1.45 | 1.22 | 1.60 | 1.07 | 0.96 |
| EPS Basic Discontinuous Ops | 0.08 | 0.01 | 0.00 | 0.04 | 1.44 |
| EPS Diluted Total Ops | 1.52 | 1.21 | 1.59 | 1.10 | 2.37 |
| EPS Diluted Continuous Ops | 1.44 | 1.20 | 1.59 | 1.06 | 0.95 |
| EPS Diluted Discontinuous Ops | 0.08 | 0.01 | 0.00 | 0.04 | 1.42 |
| EBITDA(a) | $4,631,000 | $5,258,000 | $5,543,000 | $4,425,000 | $2,971,000 |